Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 2760INDUSTRY 1605NIH 433NETWORK 86OTHER_GOV 51FED 8UNKNOWN 5INDIV 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 92Breast 59Thoracic 33Head & Neck 17Lymphoid 16CNS 11Other hematologic neoplasm 7Gynecologic 7Dermatologic 5Tumor-Agnostic 4Genitourinary 4Sarcoma 3Other solid neoplasm 3Other neoplasm 2NET 1Myeloid 1Endocrine 1

Conditions

Melanoma 4Skin Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Skin Diseases 1Ovarian Neoplasms 1Neoplasms 1Hutchinson's Melanotic Freckle 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma 1

Interventions

pembrolizumab 1Equipment and Supplies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
UNKNOWN × Dermatologic × Clear all
NCT02346955 2020-08-27

MK-6018-001

KitovPharma

Phase 1 Terminated
27 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01385943 2019-11-08

EUNET

Lucid

Withdrawn
Dermatologic

Skin Neoplasms

NCT00785369 2012-10-03

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Lucid

Phase NA Completed
441 enrolled
Dermatologic

Melanoma, Skin Diseases, Skin Neoplasms, Hutchinson's Melanotic Freckle

NCT00399113 2011-07-14

Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

PainT

Phase 1 Completed
12 enrolled
Dermatologic

Melanoma

NCT00734188 2011-07-14

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

PainT

Phase 1 Completed
21 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡